Inflection Point Investments LLP Makes New Investment in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Inflection Point Investments LLP acquired a new stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 156,899 shares of the company's stock, valued at approximately $1,265,000. Integral Ad Science makes up about 2.8% of Inflection Point Investments LLP's investment portfolio, making the stock its 9th largest position. Inflection Point Investments LLP owned approximately 0.10% of Integral Ad Science as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in IAS. Rice Hall James & Associates LLC lifted its position in shares of Integral Ad Science by 89.2% during the 4th quarter. Rice Hall James & Associates LLC now owns 314,129 shares of the company's stock valued at $3,280,000 after acquiring an additional 148,082 shares during the last quarter. Handelsbanken Fonder AB purchased a new stake in shares of Integral Ad Science during the fourth quarter valued at $162,000. Bank of New York Mellon Corp boosted its position in shares of Integral Ad Science by 13.1% in the 4th quarter. Bank of New York Mellon Corp now owns 251,091 shares of the company's stock valued at $2,621,000 after purchasing an additional 29,145 shares during the period. Oppenheimer & Co. Inc. increased its stake in Integral Ad Science by 8.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 28,040 shares of the company's stock worth $293,000 after purchasing an additional 2,069 shares in the last quarter. Finally, NINE MASTS CAPITAL Ltd acquired a new stake in Integral Ad Science during the 4th quarter worth about $671,000. 95.78% of the stock is currently owned by institutional investors.

Integral Ad Science Stock Performance

Shares of IAS stock traded up $0.18 during trading on Monday, reaching $8.33. The company had a trading volume of 1,114,418 shares, compared to its average volume of 999,668. The firm's 50 day simple moving average is $7.53 and its two-hundred day simple moving average is $9.13. Integral Ad Science Holding Corp. has a one year low of $6.26 and a one year high of $13.62. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The company has a market capitalization of $1.37 billion, a PE ratio of 41.65, a PEG ratio of 1.06 and a beta of 1.59.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.02. The firm had revenue of $134.07 million for the quarter, compared to analyst estimates of $129.20 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. Sell-side analysts forecast that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Insider Transactions at Integral Ad Science

In related news, CEO Lisa Utzschneider sold 8,367 shares of the firm's stock in a transaction on Wednesday, May 7th. The stock was sold at an average price of $7.37, for a total value of $61,664.79. Following the completion of the transaction, the chief executive officer now directly owns 349,574 shares of the company's stock, valued at $2,576,360.38. This trade represents a 2.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In the last quarter, insiders have sold 86,222 shares of company stock valued at $636,252. 2.00% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on IAS. Scotiabank initiated coverage on shares of Integral Ad Science in a report on Friday, February 28th. They set a "sector perform" rating and a $12.00 price target on the stock. Oppenheimer reiterated an "outperform" rating on shares of Integral Ad Science in a report on Friday, February 28th. Baird R W downgraded Integral Ad Science from a "strong-buy" rating to a "hold" rating in a research note on Friday, March 28th. Morgan Stanley decreased their price objective on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Finally, Truist Financial increased their target price on shares of Integral Ad Science from $16.00 to $17.00 and gave the stock a "buy" rating in a research report on Monday, March 3rd. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Integral Ad Science currently has a consensus rating of "Moderate Buy" and a consensus target price of $13.55.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.